ECM in brain aging and dementia

Progress in Brain Research

Volumn 214, Issue , 2014, Pages 207-227

  Morawski, Markus ^a   Filippov, Mikhail ^b   Tzinia, Athina ^c   Tsilibary, Effie ^c   Vargova, Lydia ^d,e  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^d CHARLES UNIVERSITY   (Czech Republic)

^e INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Alzheimer's disease; CSPG; Extracellular space; HSPG; MMP; Neuroprotection; Perineuronal nets; Plasticity

Indexed keywords

MATRIX METALLOPROTEINASE; PROTEOHEPARAN SULFATE;

AGING; ARTICLE; BRAIN; DEMENTIA; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; HUMAN; NERVE DEGENERATION; NERVE FIBER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING;

EID: 84922322731     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-63486-3.00010-4     Document Type: Chapter

References (144)

1. Allen N.J., Bennett M.L., Foo L.C., Wang G.X., Chakraborty C., Smith S.J., Barres B.A. Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature 2012, 486:410-414.
2. Almeida C.G., Tampellini D., Takahashi R.H., Greengard P., Lin M.T., Snyder E.M., Gouras G.K. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis. 2005, 20:187-198.
3. Annies M., Bittcher G., Ramseger R., Loschinger J., Woll S., Porten E., Abraham C., Ruegg M.A., Kroger S. Clustering transmembrane-agrin induces filopodia-like processes on axons and dendrites. Mol. Cell. Neurosci. 2006, 31:515-524.
4. Backstrom J.R., Lim G.P., Cullen M.J., Tokes Z.A. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). J. Neurosci. 1996, 16:7910-7919.
5. Baig S., Wilcock G.K., Love S. Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease. Acta Neuropathol. 2005, 110:393-401.
6. Baig S., Kehoe P.G., Love S. MMP-2, -3 and -9 levels and activity are not related to Abeta load in the frontal cortex in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 2008, 34:205-215.
7. Bekku Y., Vargova L., Goto Y., Vorisek I., Dmytrenko L., Narasaki M., Ohtsuka A., Fassler R., Ninomiya Y., Sykova E., Oohashi T. Bral1: its role in diffusion barrier formation and conduction velocity in the CNS. J. Neurosci. 2010, 30:3113-3123.
8. Belichenko P.V., Miklossy J., Celio M.R. HIV-I induced destruction of neocortical extracellular matrix components in AIDS victims. Neurobiol. Dis. 1997, 4:301-310.
9. Belichenko P.V., Miklossy J., Belser B., Budka H., Celio M.R. Early destruction of the extracellular matrix around parvalbumin-immunoreactive interneurons in Creutzfeldt-Jakob disease. Neurobiol. Dis. 1999, 6:269-279.
10. Biroc S.L., Payan D.G., Fisher J.M. Isoforms of agrin are widely expressed in the developing rat and may function as protease inhibitors. Brain Res. Dev. Brain Res. 1993, 75:119-129.
11. Blosa M., Sonntag M., Brückner G., Jäger C., Seeger G., Matthews R.T., Rübsamen R., Arendt T., Morawski M. Molecular heterogeneity of extracellular matrix in the mice medial nucleus of trapezoid body-implications for physiological functions?. Neuroscience 2013, 228:215-234.
12. Bondareff W. Age-related changes in brain extracellular space affect processing of amyloid peptides in Alzheimer's disease. J. Alzheimers Dis. 2013, 35:1-6.
13. Brookmeyer R., Gray S., Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am. J. Public Health 1998, 88:1337-1342.
14. Brückner G., Brauer K., Härtig W., Wolff J.R., Rickmann M.J., Derouiche A., Delpech B., Girard N., Oertel W.H., Reichenbach A. Perineuronal nets provide a polyanionic, glia-associated form of microenvironment around certain neurons in many parts of the rat brain. Glia 1993, 8:183-200.
15. Brückner G., Hausen D., Härtig W., Drlicek M., Arendt T., Brauer K. Cortical areas abundant in extracellular matrix chondroitin sulphate proteoglycans are less affected by cytoskeletal changes in Alzheimer's disease. Neuroscience 1999, 92:791-805.
16. Brückner G., Morawski M., Arendt T. Aggrecan-based extracellular matrix is an integral part of the human basal ganglia circuit. Neuroscience 2008, 151:489-504.
17. Cabungcal J.H., Steullet P., Morishita H., Kraftsik R., Cuenod M., Hensch T.K., Do K.Q. Perineuronal nets protect fast-spiking interneurons against oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:9130-9135.
18. Carulli D., Rhodes K., Brown D., Bonnert T., Pollack S., Oliver K., Strata P., Fawcett J. Composition of perineuronal nets in the adult rat cerebellum and the cellular origin of their components. J. Comp. Neurol. 2006, 494:559-577.
19. Carulli D., Pizzorusso T., Kwok J.C., Putignano E., Poli A., Forostyak S., Andrews M.R., Deepa S.S., Glant T.T., Fawcett J.W. Animals lacking link protein have attenuated perineuronal nets and persistent plasticity. Brain 2010, 133:2331-2347.
20. Castillo G.M., Ngo C., Cummings J., Wight T.N., Snow A.D. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. J. Neurochem. 1997, 69:2452-2465.
21. Chin J., Massaro C.M., Palop J.J., Thwin M.T., Yu G.Q., Bien-Ly N., Bender A., Mucke L. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease. J. Neurosci. 2007, 27:2727-2733.
22. Chun W., Johnson G.V. The role of tau phosphorylation and cleavage in neuronal cell death. Front. Biosci. 2007, 12:733-756.
23. Cotman S.L., Halfter W., Cole G.J. Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain. Mol. Cell. Neurosci. 2000, 15:183-198.
24. Deb S., Gottschall P.E. Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J. Neurochem. 1996, 66:1641-1647.
25. de Wit J., O'Sullivan M.L., Savas J.N., Condomitti G., Caccese M.C., Vennekens K.M., Yates J.R., Ghosh A. Unbiased discovery of glypican as a receptor for LRRTM4 in regulating excitatory synapse development. Neuron 2013, 79:696-711.
26. DeWitt D.A., Silver J., Canning D.R., Perry G. Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease. Exp. Neurol. 1993, 121:149-152.
27. DeWitt D.A., Richey P.L., Praprotnik D., Silver J., Perry G. Chondroitin sulfate proteoglycans are a common component of neuronal inclusions and astrocytic reaction in neurodegenerative diseases. Brain Res. 1994, 656:205-209.
28. Dityatev A., Schachner M. Extracellular matrix molecules and synaptic plasticity. Nat. Rev. Neurosci. 2003, 4:456-468.
29. Dityatev A., Dityateva G., Sytnyk V., Delling M., Toni N., Nikonenko I., Muller D., Schachner M. Polysialylated neural cell adhesion molecule promotes remodeling and formation of hippocampal synapses. J. Neurosci. 2004, 24:9372-9382.
30. Dotti C.G., De Strooper B. Alzheimer's dementia by circulation disorders: when trees hide the forest. Nat. Cell Biol. 2009, 11:114-116.
31. Ethell I.M., Yamaguchi Y. Cell surface heparan sulfate proteoglycan syndecan-2 induces the maturation of dendritic spines in rat hippocampal neurons. J. Cell Biol. 1999, 144:575-586.
32. Fatemi S.H. Reelin glycoprotein: structure, biology and roles in health and disease. Mol. Psychiatry 2005, 10:251-257.
33. Fragkouli A., Tzinia A.K., Charalampopoulos I., Gravanis A., Tsilibary E.C. Matrix metalloproteinase-9 participates in NGF-induced alpha-secretase cleavage of amyloid-beta protein precursor in PC12 cells. J. Alzheimers Dis. 2011, 24:705-719.
34. Fragkouli A., Papatheodoropoulos C., Georgopoulos S., Stamatakis A., Stylianopoulou F., Tsilibary E.C., Tzinia A.K. Enhanced neuronal plasticity and elevated endogenous sAPPalpha levels in mice over-expressing MMP9. J. Neurochem. 2012, 121:239-251.
35. Fragkouli A., Tsilibary E.C., Tzinia A.K. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice. Neurobiol. Dis. 2014, 70:179-189.
36. Fuxe K., Agnati L.F. Volume Transmission in the Brain: Novel Mechanisms for Neural Transmission 1991, Raven Press, New York.
37. Gasparini L., Dityatev A. Beta-amyloid and glutamate receptors. Exp. Neurol. 2008, 212:1-4.
38. Gawlak M., Gorkiewicz T., Gorlewicz A., Konopacki F.A., Kaczmarek L., Wilczynski G.M. High resolution in situ zymography reveals matrix metalloproteinase activity at glutamatergic synapses. Neuroscience 2009, 158:167-176.
39. Gherardini L., Gennaro M., Pizzorusso T. Perilesional treatment with chondroitinase ABC and motor training promote functional recovery after stroke in rats 2013, Cereb. Cortex., First published online: August 19, 2013. 10.1093/cercor/bht217.
40. Gottschall P.E., Deb S. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation 1996, 3:69-75.
41. Granes F., Garcia R., Casaroli-Marano R.P., Castel S., Rocamora N., Reina M., Urena J.M., Vilaro S. Syndecan-2 induces filopodia by active cdc42Hs. Exp. Cell Res. 1999, 248:439-456.
42. Groffen A.J., Buskens C.A., van Kuppevelt T.H., Veerkamp J.H., Monnens L.A., van den Heuvel L.P. Primary structure and high expression of human agrin in basement membranes of adult lung and kidney. Eur. J. Biochem. 1998, 254:123-128.
43. Gupta-Bansal R., Frederickson R.C., Brunden K.R. Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation. J. Biol. Chem. 1995, 270:18666-18671.
44. Halfter W., Dong S., Schurer B., Cole G.J. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J. Biol. Chem. 1998, 273:25404-25412.
45. Happel M.F., Niekisch H., Castiblanco Rivera L.L., Ohl F.W., Deliano M., Frischknecht R. Enhanced cognitive flexibility in reversal learning induced by removal of the extracellular matrix in auditory cortex. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:2800-2805.
46. Hebert L.E., Bienias J.L., Aggarwal N.T., Wilson R.S., Bennett D.A., Shah R.C., Evans D.A. Change in risk of Alzheimer disease over time. Neurology 2010, 75:786-791.
47. Herring A., Donath A., Steiner K.M., Widera M.P., Hamzehian S., Kanakis D., Kolble K., ElAli A., Hermann D.M., Paulus W., Keyvani K. Reelin depletion is an early phenomenon of Alzheimer's pathology. J. Alzheimers Dis. 2012, 30:963-979.
48. Hiesberger T., Trommsdorff M., Howell B.W., Goffinet A., Mumby M.C., Cooper J.A., Herz J. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 1999, 24:481-489.
49. Hilgenberg L.G., Su H., Gu H., O'Dowd D.K., Smith M.A. Alpha3Na+/K+-ATPase is a neuronal receptor for agrin. Cell 2006, 125:359-369.
50. Hobohm C., Günther A., Grosche J., Rossner S., Schneider D., Brückner G. Decomposition and long-lasting downregulation of extracellular matrix in perineuronal nets induced by focal cerebral ischemia in rats. J. Neurosci. Res. 2005, 80:539-548.
51. Hoe H.S., Tran T.S., Matsuoka Y., Howell B.W., Rebeck G.W. DAB1 and Reelin effects on amyloid precursor protein and ApoE receptor 2 trafficking and processing. J. Biol. Chem. 2006, 281:35176-35185.
52. Horstmann S., Budig L., Gardner H., Koziol J., Deuschle M., Schilling C., Wagner S. Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease. Int. Psychogeriatr. 2010, 22:966-972.
53. Hrabetova S., Masri D., Tao L., Xiao F., Nicholson C. Calcium diffusion enhanced after cleavage of negatively charged components of brain extracellular matrix by chondroitinase ABC. J. Physiol. 2009, 587:4029-4049.
54. Hsieh H., Boehm J., Sato C., Iwatsubo T., Tomita T., Sisodia S., Malinow R. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 2006, 52:831-843.
55. Hsueh Y.P., Sheng M. Regulated expression and subcellular localization of syndecan heparan sulfate proteoglycans and the syndecan-binding protein CASK/LIN-2 during rat brain development. J. Neurosci. 1999, 19:7415-7425.
56. Iliff J.J., Wang M., Liao Y., Plogg B.A., Peng W., Gundersen G.A., Benveniste H., Vates G.E., Deane R., Goldman S.A., Nagelhus E.A., Nedergaard M. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci. Transl. Med. 2012, 4:147ra111.
57. Iqbal K., Alonso Adel C., Chen S., Chohan M.O., El-Akkad E., Gong C.X., Khatoon S., Li B., Liu F., Rahman A., Tanimukai H., Grundke-Iqbal I. Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta 2005, 1739:198-210.
58. Ito S., Kimura K., Haneda M., Ishida Y., Sawada M., Isobe K. Induction of matrix metalloproteinases (MMP3, MMP12 and MMP13) expression in the microglia by amyloid-beta stimulation via the PI3K/Akt pathway. Exp. Gerontol. 2007, 42:532-537.
59. Jäger C., Lendvai D., Seeger G., Brückner G., Matthews R.T., Arendt T., Alpar A., Morawski M. Perineuronal and perisynaptic extracellular matrix in the human spinal cord. Neuroscience 2013, 238:168-184.
60. Jenkins H.G., Bachelard H.S. Glycosaminoglycans in cortical autopsy samples from Alzheimer brain. J. Neurochem. 1988, 51:1641-1645.
61. Kaksonen M., Pavlov I., Voikar V., Lauri S.E., Hienola A., Riekki R., Lakso M., Taira T., Rauvala H. Syndecan-3-deficient mice exhibit enhanced LTP and impaired hippocampus-dependent memory. Mol. Cell. Neurosci. 2002, 21:158-172.
62. Kanekiyo T., Zhang J., Liu Q., Liu C.C., Zhang L., Bu G. Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake. J. Neurosci. 2011, 31:1644-1651.
63. Knuesel I., Nyffeler M., Mormede C., Muhia M., Meyer U., Pietropaolo S., Yee B.K., Pryce C.R., LaFerla F.M., Marighetto A., Feldon J. Age-related accumulation of Reelin in amyloid-like deposits. Neurobiol. Aging 2009, 30:697-716.
64. Kobayashi K., Emson P.C., Mountjoy C.Q. Vicia villosa lectin-positive neurones in human cerebral cortex. Loss in Alzheimer-type dementia. Brain Res. 1989, 498:170-174.
65. Ksiazek I., Burkhardt C., Lin S., Seddik R., Maj M., Bezakova G., Jucker M., Arber S., Caroni P., Sanes J.R., Bettler B., Ruegg M.A. Synapse loss in cortex of agrin-deficient mice after genetic rescue of perinatal death. J. Neurosci. 2007, 27:7183-7195.
66. Kummer T.T., Misgeld T., Sanes J.R. Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost. Curr. Opin. Neurobiol. 2006, 16:74-82.
67. Kuperstein I., Broersen K., Benilova I., Rozenski J., Jonckheere W., Debulpaep M., Vandersteen A., Segers-Nolten I., Van Der Werf K., Subramaniam V., Braeken D., Callewaert G., Bartic C., D'Hooge R., Martins I.C., Rousseau F., Schymkowitz J., De Strooper B. Neurotoxicity of Alzheimer's disease Abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio. EMBO J. 2010, 29:3408-3420.
68. Lacor P.N., Buniel M.C., Furlow P.W., Clemente A.S., Velasco P.T., Wood M., Viola K.L., Klein W.L. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J. Neurosci. 2007, 27:796-807.
69. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., Klein W.L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:6448-6453.
70. Lauren J., Gimbel D.A., Nygaard H.B., Gilbert J.W., Strittmatter S.M. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009, 457:1128-1132.
71. Lendvai D., Morawski M., Negyessy L., Gati G., Jager C., Baksa G., Glasz T., Attems J., Tanila H., Arendt T., Harkany T., Alpar A. Neurochemical mapping of the human hippocampus reveals perisynaptic matrix around functional synapses in Alzheimer's disease. Acta Neuropathol. 2013, 125:215-229.
72. Li W., Poteet E., Xie L., Liu R., Wen Y., Yang S.H. Regulation of matrix metalloproteinase 2 by oligomeric amyloid beta protein. Brain Res. 2011, 1387:141-148.
73. Liao M.C., Van Nostrand W.E. Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro. Biochemistry 2010, 49:1127-1136.
74. Lin Y.L., Lei Y.T., Hong C.J., Hsueh Y.P. Syndecan-2 induces filopodia and dendritic spine formation via the neurofibromin-PKA-Ena/VASP pathway. J. Cell Biol. 2007, 177:829-841.
75. Litwack E.D., Ivins J.K., Kumbasar A., Paine-Saunders S., Stipp C.S., Lander A.D. Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent. Dev. Dyn. 1998, 211:72-87.
76. Massey J.M., Amps J., Viapiano M.S., Matthews R.T., Wagoner M.R., Whitaker C.M., Alilain W., Yonkof A.L., Khalyfa A., Cooper N.G.F., Silver J., Onifer S.M. Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp. Neurol. 2008, 209:426-445.
77. Matsumoto-Miyai K., Sokolowska E., Zurlinden A., Gee C.E., Luscher D., Hettwer S., Wolfel J., Ladner A.P., Ster J., Gerber U., Rulicke T., Kunz B., Sonderegger P. Coincident pre- and postsynaptic activation induces dendritic filopodia via neurotrypsin-dependent agrin cleavage. Cell 2009, 136:1161-1171.
78. McCroskery S., Bailey A., Lin L., Daniels M.P. Transmembrane agrin regulates dendritic filopodia and synapse formation in mature hippocampal neuron cultures. Neuroscience 2009, 163:168-179.
79. McEwen B.S. Stress and hippocampal plasticity. Annu. Rev. Neurosci. 1999, 22:105-122.
80. Medina-Flores R., Wang G., Bissel S.J., Murphey-Corb M., Wiley C.A. Destruction of extracellular matrix proteoglycans is pervasive in simian retroviral neuroinfection. Neurobiol. Dis. 2004, 16:604-616.
81. Meighan P.C., Meighan S.E., Davis C.J., Wright J.W., Harding J.W. Effects of matrix metalloproteinase inhibition on short- and long-term plasticity of schaffer collateral/CA1 synapses. J. Neurochem. 2007, 102:2085-2096.
82. Miosge N., Simniok T., Sprysch P., Herken R. The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo. J Histochem Cytochem. 2003, 51:285-296.
83. Miyata S., Nishimura Y., Nakashima T. Perineuronal nets protect against amyloid beta-protein neurotoxicity in cultured cortical neurons. Brain Res. 2007, 1150:200-206.
84. Mlekusch R., Humpel C. Matrix metalloproteinases-2 and -3 are reduced in cerebrospinal fluid with low beta-amyloid1-42 levels. Neurosci. Lett. 2009, 466:135-138.
85. Morawski M., Reinert T., Brückner G., Wagner F.E., Butz T., Arendt T., Tröger W. The binding of Fe to perineuronal nets: a combined nuclear microscopy and Mössbauer Study. Hyperfine Interact. 2004, 159:285-291.
86. Morawski M., Brückner M.K., Riederer P., Brückner G., Arendt T. Perineuronal nets potentially protect against oxidative stress. Exp. Neurol. 2004, 188:309-315.
87. Morawski M., Brückner G., Jäger C., Seeger G., Arendt T. Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer's disease. Neuroscience 2010, 169:1347-1363.
88. Morawski M., Pavlica S., Seeger G., Grosche J., Kouznetsova E., Schliebs R., Brückner G., Arendt T. Perineuronal nets are largely unaffected in Alzheimer model Tg2576 mice. Neurobiol. Aging 2010, 31:1254-1256.
89. Morawski M., Brückner G., Jager C., Seeger G., Matthews R.T., Arendt T. Involvement of perineuronal and perisynaptic extracellular matrix in Alzheimer's disease neuropathology. Brain Pathol. 2012, 22:547-561.
90. Mroczko B., Groblewska M., Zboch M., Kulczynska A., Koper O.M., Szmitkowski M., Kornhuber J., Lewczuk P. Concentrations of matrix metalloproteinases and their tissue inhibitors in the cerebrospinal fluid of patients with Alzheimer's disease. J. Alzheimers Dis. 2014, 40:351-357.
91. Murdoch A.D., Iozzo R.V. Perlecan: the multidomain heparan sulphate proteoglycan of basement membrane and extracellular matrix. Virchows Arch. A Pathol. Anat. Histopathol. 1993, 423:237-242.
92. Nagase H., Woessner J.F. Matrix metalloproteinases. J. Biol. Chem. 1999, 274:21491-21494.
93. Noguchi A., Matsumura S., Dezawa M., Tada M., Yanazawa M., Ito A., Akioka M., Kikuchi S., Sato M., Ideno S., Noda M., Fukunari A., Muramatsu S., Itokazu Y., Sato K., Takahashi H., Teplow D.B., Nabeshima Y., Kakita A., Imahori K., Hoshi M. Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains. J. Biol. Chem. 2009, 284:32895-32905.
94. O'Callaghan P., Sandwall E., Li J.P., Yu H., Ravid R., Guan Z.Z., van Kuppevelt T.H., Nilsson L.N., Ingelsson M., Hyman B.T., Kalimo H., Lindahl U., Lannfelt L., Zhang X. Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells. Brain Pathol. 2008, 18:548-561.
95. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
96. Ogawa M., Miyata T., Nakajima K., Yagyu K., Seike M., Ikenaka K., Yamamoto H., Mikoshiba K. The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons. Neuron 1995, 14:899-912.
97. Parodi J., Sepulveda F.J., Roa J., Opazo C., Inestrosa N.C., Aguayo L.G. Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure. J. Biol. Chem. 2010, 285:2506-2514.
98. Perry G., Siedlak S.L., Richey P., Kawai M., Cras P., Kalaria R.N., Galloway P.G., Scardina J.M., Cordell B., Greenberg B.D., et al. Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease. J. Neurosci. 1991, 11:3679-3683.
99. Pizzorusso T., Medini P., Berardi N., Chierzi S., Fawcett J.W., Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002, 298:1248-1251.
100. Ramos-Moreno T., Galazo M.J., Porrero C., Martinez-Cerdeno V., Clasca F. Extracellular matrix molecules and synaptic plasticity: immunomapping of intracellular and secreted Reelin in the adult rat brain. Eur. J. Neurosci. 2006, 23:401-422.
101. Riedel A., Miettinen R., Stieler J., Mikkonen M., Alafuzoff I., Soininen H., Arendt T. Reelin-immunoreactive Cajal-Retzius cells: the entorhinal cortex in normal aging and Alzheimer's disease. Acta Neuropathol. 2003, 106:291-302.
102. Robakis N.K., Ramakrishna N., Wolfe G., Wisniewski H.M. Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:4190-4194.
103. Roitbak T., Sykova E. Diffusion barriers evoked in the rat cortex by reactive astrogliosis. Glia 1999, 28:40-48.
104. Romberg C., Yang S., Melani R., Andrews M.R., Horner A.E., Spillantini M.G., Bussey T.J., Fawcett J.W., Pizzorusso T., Saksida L.M. Depletion of perineuronal nets enhances recognition memory and long-term depression in the perirhinal cortex. J. Neurosci. 2013, 33:7057-7065.
105. Saarela M.S., Lehtimaki T., Rinne J.O., Hervonen A., Jylha M., Roytta M., Ahonen J.P., Mattila K.M. Interaction between matrix metalloproteinase 3 and the epsilon4 allele of apolipoprotein E increases the risk of Alzheimer's disease in Finns. Neurosci. Lett. 2004, 367:336-339.
106. Sanes J.R., Lichtman J.W. Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat. Rev. Neurosci. 2001, 2:791-805.
107. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., Farrell M.A., Rowan M.J., Lemere C.A., Regan C.M., Walsh D.M., Sabatini B.L., Selkoe D.J. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 2008, 14:837-842.
108. Siddiqui T.J., Tari P.K., Connor S.A., Zhang P., Dobie F.A., She K., Kawabe H., Wang Y.T., Brose N., Craig A.M. An LRRTM4-HSPG complex mediates excitatory synapse development on dentate gyrus granule cells. Neuron 2013, 79:680-695.
109. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5:146-156.
110. Snow A.D., Mar H., Nochlin D., Sekiguchi R.T., Kimata K., Koike Y., Wight T.N. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am. J. Pathol. 1990, 137:1253-1270.
111. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., Greengard P. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 2005, 8:1051-1058.
112. Soleman S., Filippov M.A., Dityatev A., Fawcett J.W. Targeting the neural extracellular matrix in neurological disorders. Neuroscience 2013, 253:194-213.
113. Stephan A., Mateos J.M., Kozlov S.V., Cinelli P., Kistler A.D., Hettwer S., Rulicke T., Streit P., Kunz B., Sonderegger P. Neurotrypsin cleaves agrin locally at the synapse. FASEB J. 2008, 22:1861-1873.
114. Stomrud E., Bjorkqvist M., Janciauskiene S., Minthon L., Hansson O. Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease. Alzheimers Res. Ther. 2010, 2:20.
115. Stranahan A.M., Haberman R.P., Gallagher M. Cognitive decline is associated with reduced reelin expression in the entorhinal cortex of aged rats. Cereb. Cortex 2011, 21:392-400.
116. Stranahan A.M., Erion J.R., Wosiski-Kuhn M. Reelin signaling in development, maintenance, and plasticity of neural networks. Ageing Res. Rev. 2013, 12:815-822.
117. Suttkus A., Rohn S., Weigel S., Glockner P., Arendt T., Morawski M. Aggrecan, link protein and tenascin-R are essential components of the perineuronal net to protect neurons against iron-induced oxidative stress. Cell Death Dis. 2014, 5:e1119.
118. Suzuki S., Katzman R., Korey S.R. Chemical studies on Alzheimer's disease. J. Neuropathol. Exp. Neurol. 1965, 24:211-224.
119. Sykova E. Extrasynaptic volume transmission and diffusion parameters of the extracellular space. Neuroscience 2004, 129:861-876.
120. Sykova E., Mazel T., Hasenohrl R.U., Harvey A.R., Simonova Z., Mulders W.H., Huston J.P. Learning deficits in aged rats related to decrease in extracellular volume and loss of diffusion anisotropy in hippocampus. Hippocampus 2002, 12:269-279.
121. Sykova E., Vorisek I., Antonova T., Mazel T., Meyer-Luehmann M., Jucker M., Hajek M., Ort M., Bures J. Changes in extracellular space size and geometry in APP23 transgenic mice: a model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:479-484.
122. Sykova E., Vorisek I., Mazel T., Antonova T., Schachner M. Reduced extracellular space in the brain of tenascin-R- and HNK-1-sulphotransferase deficient mice. Eur. J. Neurosci. 2005, 22:1873-1880.
123. Szklarczyk A., Lapinska J., Rylski M., McKay R.D., Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J. Neurosci. 2002, 22:920-930.
124. Talamagas A.A., Efthimiopoulos S., Tsilibary E.C., Figueiredo-Pereira M.E., Tzinia A.K. Abeta(1-40)-induced secretion of matrix metalloproteinase-9 results in sAPPalpha release by association with cell surface APP. Neurobiol. Dis. 2007, 28:304-315.
125. Thorne R.G., Lakkaraju A., Rodriguez-Boulan E., Nicholson C. In vivo diffusion of lactoferrin in brain extracellular space is regulated by interactions with heparan sulfate. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:8416-8421.
126. Tozaki H., Matsumoto A., Kanno T., Nagai K., Nagata T., Yamamoto S., Nishizaki T. The inhibitory and facilitatory actions of amyloid-beta peptides on nicotinic ACh receptors and AMPA receptors. Biochem. Biophys. Res. Commun. 2002, 294:42-45.
127. Vaillant C., Didier-Bazes M., Hutter A., Belin M.F., Thomasset N. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. J. Neurosci. 1999, 19:4994-5004.
128. van Horssen J., Wilhelmus M.M., Heljasvaara R., Pihlajaniemi T., Wesseling P., de Waal R.M., Verbeek M.M. Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloid depositions and senile plaques in Alzheimer's disease brains. Brain Pathol. 2002, 12:456-462.
129. Verbeek M.M., Otte-Holler I., van den Born J., van den Heuvel L.P., David G., Wesseling P., de Waal R.M. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain. Am. J. Pathol. 1999, 155:2115-2125.
130. Vidal E., Bolea R., Tortosa R., Costa C., Domènech A., Monleón E., Vargas A., Badiola J.J., Pumarola M. Assessment of calcium-binding proteins (Parvalbumin and Calbindin D-28K) and perineuronal nets in normal and scrapie-affected adult sheep brains. J. Viral. Methods 2006, 136:137-146.
131. Vizi E.S., Kiss J.P., Lendvai B. Monosynaptic communication in the central nervous system. Neurochem. Int. 2004, 45:443-451.
132. Vorisek I., Namestkova K., Hajek M., Sykova E. Decreased mean diffusivity in the brain tissue of aged rats with learning deficits. Proc. Int. Soc. Man. Reson. Med. 2005, 13:398.
133. Wenk G.L. Neuropathology changes in Alzheimer's disease. J. Clan. Psychiatry 2003, 64(Suppl. 9):7-10.
134. White A.R., Du T., Laughton K.M., Volitakis I., Sharples R.A., Xilinas M.E., Hoke D.E., Holsinger R.M., Evin G., Cherny R.A., et al. Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity. J. Biol. Chem. 2006, 281:17670-17680.
135. Wolak D.J., Thorne R.G. Diffusion of macromolecules in the brain: implications for drug delivery. Mol. Pharm. 2013, 10:1492-1504.
136. Xie L., Kang H., Xu Q., Chen M.J., Liao Y., Thiyagarajan M., O'Donnell J., Christensen D.J., Nicholson C., Iliff J.J., Takano T., Deane R., Nedergaard M. Sleep drives metabolite clearance from the adult brain. Science 2013, 342:373-377.
137. Yamaguchi Y. Lecticans: organizers of the brain extracellular matrix. Cell. Mol. Life Sci. 2000, 57:276-289.
138. Yan P., Hu X., Song H., Yin K., Bateman R.J., Cirrito J.R., Xiao Q., Hsu F.F., Turk J.W., Xu J., et al. Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ. J. Biol. Chem. 2006, 281:24566-24574.
139. Yasuhara O., Akiyama H., McGeer E.G., McGeer P.L. Immunohistochemical localization of hyaluronic acid in rat and human brain. Brain Res. 1994, 635:269-282.
140. Yin K.J., Cirrito J.R., Yan P., Hu X., Xiao Q., Pan X., Bateman R., Song H., Hsu F.F., Turk J., Xu J., Hsu C.Y., Mills J.C., Holtzman D.M., Lee J.M. Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J. Neurosci. 2006, 26:10939-10948.
141. Yoshiyama Y., Asahina M., Hattori T. Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain. Acta Neuropathol. 2000, 99:91-95.
142. Zamecnik J., Vargova L., Homola A., Kodet R., Sykova E. Extracellular matrix glycoproteins and diffusion barriers in human astrocytic tumours. Neuropathol. Appl. Neurobiol. 2004, 30:338-350.
143. Zamecnik J., Homola A., Cicanic M., Kuncova K., Marusic P., Krsek P., Sykova E., Vargova L. The extracellular matrix and diffusion barriers in focal cortical dysplasias. Eur. J. Neurosci. 2012, 36:2017-2024.
144. Zhang X., Wang B., O'Callaghan P., Hjertstrom E., Jia J., Gong F., Zcharia E., Nilsson L.N., Lannfelt L., Vlodavsky I., Lindahl U., Li J.P. Heparanase overexpression impairs inflammatory response and macrophage-mediated clearance of amyloid-beta in murine brain. Acta Neuropathol. 2012, 124:465-478.